SEC Form 4 · accession 0001408408-17-000013
iBio, Inc. · IBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Bryan Dart
10% Owner
Period of report
Feb 23, 2017
Accepted (ET)
Feb 27, 2017 · 3:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420720
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Preferred StockF1 | Feb 23, 2017 | P$0 | 1 | — | A | 1 | I | By Company |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On February 23, 2017, an entity indirectly owned 100% by Kenneth B. Dart ("the Affiliate") acquired one (1) share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Stock") in exchange for 29,990,000 units of limited liability company interests of iBio CMO LLC ("Units") held by the Affiliate. iBio CMO LLC is a subsidiary of the Issuer. The shares of the Preferred Stock are exchangeable for Units only after March 31, 2018 ("Mandatory Exchange"), or an event which triggers a change of control of iBio CMO LLC, or in connection with a winding up, liquidation or deemed liquidation (such as a merger) of the Issuer or iBio CMO. The Preferred Stock is not convertible into or exchangeable for any of the Issuer's securities. The Preferred Stock has no voting rights with respect to the Issuer.